BioSpace News Archive

Drug Development

HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

Data demonstrate responses and stable disease in some head and neck cancer patients who all received at least two prior therapies and progressed on a PD1 inhibitor

December 7, 2020
·
9 min read
Pharm Country

Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology

Matinas BioPharma Holdings, Inc. announced that they plan to collaborate with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to test oral formulations of remdesivir in preclinical models.

December 7, 2020
·
6 min read
Deals

Matinas BioPharma Files Preliminary Proxy for Special Meeting of Stockholders

Special Meeting of Stockholders Scheduled for January 26, 2021 Seeking Authorization to Potentially Effectuate a Discretionary Reverse Stock SplitPrior to January 26, 2022

December 7, 2020
·
6 min read
Lexaria to Highlight its DehydraTECHTM Technology at Four Upcoming Investor Conferences

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announced that its Chairman & CEO Chris Bunka is scheduled to present at four upcoming investor conferences in December 2020 and January 2021.

December 7, 2020
·
5 min read
Sequana Medical to Host KOL Event on “The Challenge of Diuretic Resistance in the Management of Heart Failure Patients and the Potential for alfapump® DSR therapy”

Sequana Medical NV announces that it will hold a key opinion leader event on the challenge of diuretic resistance in the management of heart failure patients and the potential for alfapump® DSR therapy, on Friday 11 December 2020 at 03:00 pm CET / 09:00 am EST.

December 7, 2020
·
7 min read
Blood Plasma Market: Increased Prevalence of Cases of Hemophilia to Support Growth of the Market

Blood plasma refers to the liquid part of the blood. It is a versatile element and it comprises around 55% of the blood.

December 7, 2020
·
3 min read
AI in Diagnostic Imaging Market: Higher Appropriation of Cutting Edge Clinical Imaging Innovations to Drive the Market

AI in diagnostic imaging is gaining prominence and quickly growing industry close to what’s to come.

December 7, 2020
·
5 min read
Drug Development

NeuroRx and Relief Therapeutics Meet 165 Patient Enrollment Target in Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure

NeuroRx, Inc. and Relief Therapeutics Holdings AG announced that they have met the 165 patient enrollment target agreed with the U.S. Food and Drug Administration in the ongoing phase 2b/3 trial of RLF-100™ for treating Respiratory Failure in patients with Critical COVID-19.

December 7, 2020
·
7 min read
Luciferase Assays Market: Considerable Technological Progress and Growing Importance to Accentuate Market Demand

The luciferase assay is utilized in the determination of whether a protein can repress or activate the expression of a gene that has been targeted.

December 7, 2020
·
4 min read
Lateral Flow Assay Market | Current Scenario with Future Scope Analysis Report

The high prevalence of infectious diseases globally, rapidly aging population, growing demand for point-of-care testing, and home-based lateral flow assay devices are the major factors driving the growth of this market.

December 7, 2020
·
3 min read